Zobrazeno 1 - 7 of 7 pro vyhledávání: '"Michelle V, Dietz"'
1
Akademický článek
Adjuvant dendritic cell-based immunotherapy after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with malignant peritoneal mesothelioma: a phase II clinical trial
Autor: Nadine L de Boer, Job P van Kooten, Cornelis Verhoef, Joachim G J V Aerts, Eva V E Madsen, Alexandra R M Brandt-Kerkhof, Marcella Willemsen, Michelle V Dietz, Katrien L A Quintelier, Madelief Vink, Yvan Saeys, Sofie Van Gassen
Publikováno v: Journal for ImmunoTherapy of Cancer, Vol 11, Iss 8 (2023)
Background Malignant peritoneal mesothelioma (MPM) is an aggressive malignancy with a poor prognosis. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) improves survival outcomes, but recurrence rates remain high. Dend
Externí odkaz: https://doaj.org/article/4969d9c96188451cb2fee28a466fa4a5
Zobrazit plný text záznamu
3
Treatment and Survival Outcomes for Patients with Colorectal Peritoneal Metastases Deemed Ineligible for Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Results of a Retrospective Study
Autor: Michelle V. Dietz, Merijn J. Ziekman, Job P. van Kooten, Alexandra R. M. Brandt-Kerkhof, Esther van Meerten, Cornelis Verhoef, Eva V. E. Madsen
Publikováno v: Annals of Surgical Oncology, 30(4), 2048-2056. Springer New York
Background: Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is a treatment option for selected patients with colorectal peritoneal metastases (PM). This report provides an overview of treatment and survival outcomes
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73f8ae07aa4ca5b4a745dcf0f6559408
https://pure.eur.nl/en/publications/81be2733-09c6-43d4-9b16-34636d0a5d39
Zobrazit plný text záznamu
5
The Impact of Low Skeletal Muscle Mass on Short- and Long-Term Outcomes After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Autor: Michelle V. Dietz, Job P. van Kooten, Jeroen L. A. van Vugt, Alexandra R. M. Brandt-Kerkhof, Cornelis Verhoef, Eva V. E. Madsen
Publikováno v: Annals of Surgical Oncology, 29(9), 5830-5841. Springer New York
Background Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is a potentially curative treatment for peritoneal metastases from colorectal cancer (CRC) or pseudomyxoma peritonei (PMP). Because of the considerable morb
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10af936e8e8113d01b00752b65b9421d
https://pure.eur.nl/en/publications/499e574a-4eaf-4d80-9068-34d911591c61
Zobrazit plný text záznamu
6
Treatment and Survival Outcomes for Patients with Colorectal Peritoneal Metastases Deemed Ineligible for Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Results of a Retrospective Study
Autor: Michelle V, Dietz, Merijn J, Ziekman, Job P, van Kooten, Alexandra R M, Brandt-Kerkhof, Esther, van Meerten, Cornelis, Verhoef, Eva V E, Madsen
Publikováno v: Annals of surgical oncology.
Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is a treatment option for selected patients with colorectal peritoneal metastases (PM). This report provides an overview of treatment and survival outcomes for patient
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::2ee772b967bf37303e4c94d76d404e3e
https://pubmed.ncbi.nlm.nih.gov/36566258
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje